With latest advances in molecular diagnostic strategies and targeted cancer therapies, several molecular tests have already been recommended for gastric cancer (GC) and colorectal cancer (CRC). microsatellite unpredictable CRCs, and therefore is effective for ruling out Lynch symptoms. Furthermore, the mutation is normally a prognostic biomarker as well as the mutation is normally a molecular… Continue reading With latest advances in molecular diagnostic strategies and targeted cancer therapies,